Akston Biosciences Statistics
Total Valuation
AXTN has a market cap or net worth of $67.99 million. The enterprise value is $75.98 million.
| Market Cap | 67.99M |
| Enterprise Value | 75.98M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
AXTN has 7.55 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 7.55M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 48.74.
| PE Ratio | 48.74 |
| Forward PE | n/a |
| PS Ratio | 9.76 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 54.47 |
| EV / Sales | 10.90 |
| EV / EBITDA | 15.24 |
| EV / EBIT | 23.37 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | 0.70 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.19 |
| Debt / FCF | n/a |
| Interest Coverage | 1.86 |
Financial Efficiency
Return on equity (ROE) is -10.73% and return on invested capital (ROIC) is 814.46%.
| Return on Equity (ROE) | -10.73% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 814.46% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $107,203 |
| Profits Per Employee | $21,461 |
| Employee Count | 65 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AXTN has paid $105,000 in taxes.
| Income Tax | 105,000 |
| Effective Tax Rate | 7.00% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AXTN had revenue of $6.97 million and earned $1.39 million in profits. Earnings per share was $0.18.
| Revenue | 6.97M |
| Gross Profit | 232,579 |
| Operating Income | -18.36M |
| Pretax Income | 1.50M |
| Net Income | 1.39M |
| EBITDA | 4.98M |
| EBIT | 3.25M |
| Earnings Per Share (EPS) | $0.18 |
Full Income StatementBalance Sheet
The company has $2.91 million in cash and $10.91 million in debt, giving a net cash position of -$8.00 million or -$1.06 per share.
| Cash & Cash Equivalents | 2.91M |
| Total Debt | 10.91M |
| Net Cash | -8.00M |
| Net Cash Per Share | -$1.06 |
| Equity (Book Value) | -13.00M |
| Book Value Per Share | -1.72 |
| Working Capital | 1.24M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$15.08 million and capital expenditures -$942,123, giving a free cash flow of -$16.03 million.
| Operating Cash Flow | -15.08M |
| Capital Expenditures | -942,123 |
| Free Cash Flow | -16.03M |
| FCF Per Share | -$2.12 |
Full Cash Flow StatementMargins
Gross margin is 3.34%, with operating and profit margins of -263.53% and 20.02%.
| Gross Margin | 3.34% |
| Operating Margin | -263.53% |
| Pretax Margin | 21.53% |
| Profit Margin | 20.02% |
| EBITDA Margin | 71.53% |
| EBIT Margin | 46.65% |
| FCF Margin | -229.98% |
